Probiotics (lactofem) in the prevention of recurrence of infection in acute uncomplicated cystitis

Evaluation of the probiotic,s(lactofem) efficacy and complication on acute non complicated cystitis infection among women of reproductive age

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201005048943N1

Enrollment

Registered

2020-12-11

Start date

2020-11-21

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute uncomplicated cystitis. Acute cystitis

Interventions

Intervention 1: Intervention group: The probiotic lactofem made by the bio-fermentation company starts at the rate of one per day.The drug is administered in the afternoon and 5 hours after lunch with

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All premenopausal women with UTI Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Patients who have needed long-term prophylactic antibiotics due to recurrent urinary tract infections in the last 6 months. Patients who have a urinary catheter

Design outcomes

Primary

Measure	Time frame
Reduce relapse. Timepoint: At the beginning of the study and at the end of each month, patients will be visited during the study period. Method of measurement: Ask the patient about changes in the patient as well as urinary symptoms and gastrointestinal complications.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShokouh Shayanpour

Ahvaz University of Medical Sciences

dr.shayanpour@yahoo.com+98 61 3311 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026